^
Association details:
| Biomarker: | No biomarker |
|---|---|
| Cancer: | Acute Lymphocytic Leukemia |
| Drug: | ifosfamide (Bifunctional alkylating agent) + etoposide oral (Topoisomerase II inhibitor, DNA inhibitor) + mitoxantrone (Topoisomerase II inhibitor) |
| Direction: | Sensitive |
Evidence:
Source:
Excerpt:
Acute Lymphoblastic Leukemia: Other Recommended regimens…Alkylator combination regimens: eg, etoposide, ifosfamide, mitoxantrone
